+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vivus - logo

VIVUS is a biopharmaceutical company that develops and commercializes therapies to address unmet medical needs in the United States and the European Union. The company’s lead product Qsymia is a combination appetite suppressant/stimulant and seizure medication indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in overweight and obese adults. VIVUS was founded in 1991 and is headquartered in Campbell, California.

From
From
From
From
Erectile Dysfunction (ED) Drugs Market 2025-2029 - Product Thumbnail Image

Erectile Dysfunction (ED) Drugs Market 2025-2029

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Premature Ejaculation Treatment Market 2025-2029 - Product Thumbnail Image

Premature Ejaculation Treatment Market 2025-2029

  • Report
  • December 2024
  • 201 Pages
  • Global
From
From
Premature Ejaculation Disorder Market in US 2024-2028 - Product Thumbnail Image

Premature Ejaculation Disorder Market in US 2024-2028

  • Report
  • November 2023
  • 152 Pages
  • United States
From
Human Reproductive Technologies: Products and Global Markets - Product Thumbnail Image

Human Reproductive Technologies: Products and Global Markets

  • Report
  • July 2022
  • 193 Pages
  • Global
From
From
From
Drugs for Erectile Dysfunction Market Report 2025 - Product Thumbnail Image

Drugs for Erectile Dysfunction Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Market Report 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Cystic Fibrosis (CF) Therapeutics Market Report 2025 - Product Thumbnail Image

Cystic Fibrosis (CF) Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator